We are live on
!
Find out more
SA
Strategic Advocates Portfolio holdings
AUM
$25.8M
1-Year Est. Return
36.11%
This Fund
S&P 500
This Quarter
Est. Return
+23.62%
1 Year Est. Return
+36.11%
3 Year Est. Return
+103.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$25.8M
AUM Growth
+$3.23M
(+14%)
Cap. Flow
+$909
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
42.51%
Holding
286
New
19
Increased
69
Reduced
67
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard High Dividend Yield ETF
VYM
|
+$232K |
| 2 |
SCHR
Schwab Intermediately-Term US Treasury ETF
SCHR
|
+$125K |
| 3 |
Vanguard Consumer Staples ETF
VDC
|
+$119K |
| 4 |
Schwab International Equity ETF
SCHF
|
+$112K |
| 5 |
Amphenol
APH
|
+$90.7K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Healthcare ETF
IYH
|
+$169K |
| 2 |
Fidelity Low Volatility Factor ETF
FDLO
|
+$145K |
| 3 |
Boston Scientific
BSX
|
+$71.8K |
| 4 |
Chevron
CVX
|
+$62.1K |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$59.1K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 61.47% |
| 2 | Technology | 19.07% |
| 3 | Industrials | 6.77% |
| 4 | Consumer Discretionary | 3.15% |
| 5 | Healthcare | 2.64% |
Similar funds
SCA
MP
BCM
MGM
HFG
SP
IW
DPRC
Strategic Advocates's Q2 2026 Portfolio in Review
As of Q2 2026, Strategic Advocates held 286 positions worth $25.8M, up 14% from $22.6M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Strategic Advocates's Q2 2026 filing shows 19 new, 69 increased, 67 reduced and 27 closed positions. Its largest new stake was Lam Research: 250 shares worth $108K. The largest sale was iShares US Healthcare ETF, an estimated $169K.
By sector, the portfolio is most concentrated in Miscellaneous at 61% of assets, down from 65% a quarter earlier, followed by Technology and Industrials.
- Strategic Advocates's largest Q2 2026 buy was Lam Research: 250 shares worth $108K.
- Strategic Advocates added most to Vanguard High Dividend Yield ETF in Q2 2026, an estimated $232K increase.
- Strategic Advocates's biggest Q2 2026 reduction was iShares US Healthcare ETF, cutting an estimated $169K.
- Strategic Advocates fully exited Chevron in Q2 2026, selling an estimated $62.1K.
- Strategic Advocates's ten largest holdings make up 43% of its $25.8M portfolio in Q2 2026.
- Strategic Advocates opened 19 new positions and closed 27 in Q2 2026.
- Strategic Advocates's portfolio value rose 14% quarter-over-quarter to $25.8M.
Based on Strategic Advocates's 13F filing for Q2 2026, filed 13 Aug 2026.